iTonic Holdings Ltd.
iTonic Holdings Ltd.
Your view on ITOC
Overview
What the company does, where it operates, and who runs it.
About iTonic Holdings Ltd.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Jianfei Zhang
- Headquarters
- NET Building, Room 306, Hong Jun Ying South Road, Beijing, BE, CN
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Jianfei Zhang
- Headquarters
- NET Building, Room 306, Hong Jun Ying South Road, Beijing, BE, CN
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy.
Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size.
Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients.
Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for iTonic Holdings Ltd., and the rating behind it. ITOC last traded at $0.25; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for iTonic Holdings Ltd.. Starting points for iTonic Holdings Ltd.: EPS -$0.12, beta 2.79 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for iTonic Holdings Ltd.. iTonic Holdings Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for iTonic Holdings Ltd.. Trailing twelve-month EPS for iTonic Holdings Ltd. stands at -$0.12. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for iTonic Holdings Ltd.. iTonic Holdings Ltd. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
iTonic Holdings Ltd. valued side by side against its closest peers. iTonic Holdings Ltd. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold iTonic Holdings Ltd., and how their positions are changing. At a $2.4M market value, institutional positions materially move iTonic Holdings Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by iTonic Holdings Ltd. executives and directors. Shares of iTonic Holdings Ltd. have traded between $0.22 and $1.18 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming iTonic Holdings Ltd.. iTonic Holdings Ltd. is a $2.4M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming iTonic Holdings Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for iTonic Holdings Ltd.. Coverage tracks iTonic Holdings Ltd. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.